# Arxis, Inc.: financial statements, quarterly ARXS · Nasdaq · CIK 2093536 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/arxs.md) · [Financials](/companies/arxs/financials.md) · [Filings](/companies/arxs/filings.md) · [Insiders](/companies/arxs/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/arxs/financials.md?period=annual). ## Income statement | Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [380](/filings/0001193125-26-243043.md) | [400](/filings/0001193125-26-325027.md) | [415](/filings/0001193125-26-437000.md) | [459](/filings/0001193125-26-243043.md) | [501](/filings/0001193125-26-325027.md) | [564](/filings/0001193125-26-437000.md) | | Cost of revenue | $m | [217](/filings/0001193125-26-243043.md) | [203](/filings/0001193125-26-325027.md) | [211](/filings/0001193125-26-437000.md) | [224](/filings/0001193125-26-243043.md) | [238](/filings/0001193125-26-325027.md) | [258](/filings/0001193125-26-437000.md) | | Gross profit | $m | [163](/filings/0001193125-26-243043.md) | [198](/filings/0001193125-26-325027.md) | [204](/filings/0001193125-26-437000.md) | [235](/filings/0001193125-26-243043.md) | [263](/filings/0001193125-26-325027.md) | [306](/filings/0001193125-26-437000.md) | | Selling, general and administrative | $m | [68.6](/filings/0001193125-26-243043.md) | [80.6](/filings/0001193125-26-325027.md) | [77.3](/filings/0001193125-26-437000.md) | [88.3](/filings/0001193125-26-243043.md) | [194](/filings/0001193125-26-325027.md) | [132](/filings/0001193125-26-437000.md) | | Operating income | $m | [60.2](/filings/0001193125-26-243043.md) | [82.9](/filings/0001193125-26-325027.md) | [92.1](/filings/0001193125-26-437000.md) | [111](/filings/0001193125-26-243043.md) | [32.7](/filings/0001193125-26-325027.md) | [133](/filings/0001193125-26-437000.md) | | Income tax | $m | [(2.5)](/filings/0001193125-26-243043.md) | [58.3](/filings/0001193125-26-325027.md) | [54.9](/filings/0001193125-26-437000.md) | [15.7](/filings/0001193125-26-243043.md) | [3.5](/filings/0001193125-26-325027.md) | [36.0](/filings/0001193125-26-437000.md) | | Net income | $m | [(4.3)](/filings/0001193125-26-437000.md) | [(29.3)](/filings/0001193125-26-437000.md) | [(10.1)](/filings/0001193125-26-437000.md) | [53.3](/filings/0001193125-26-437000.md) | [(4.9)](/filings/0001193125-26-437000.md) | [83.7](/filings/0001193125-26-437000.md) | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | [(0.01)](/filings/0001193125-26-325027.md) | [0.20](/filings/0001193125-26-437000.md) | | Basic EPS | $ per share | not reported | not reported | not reported | not reported | [(0.01)](/filings/0001193125-26-325027.md) | [0.20](/filings/0001193125-26-437000.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [250](/filings/0001193125-26-437000.md) | [239](/filings/0001193125-26-243043.md) | [495](/filings/0001193125-26-325027.md) | [494](/filings/0001193125-26-437000.md) | | Current assets | $m | [908](/filings/0001193125-26-437000.md) | [944](/filings/0001193125-26-243043.md) | [1,235](/filings/0001193125-26-325027.md) | [1,337](/filings/0001193125-26-437000.md) | | Total assets | $m | [6,596](/filings/0001193125-26-437000.md) | [6,640](/filings/0001193125-26-243043.md) | [7,007](/filings/0001193125-26-325027.md) | [8,053](/filings/0001193125-26-437000.md) | | Current liabilities | $m | [287](/filings/0001193125-26-437000.md) | [255](/filings/0001193125-26-243043.md) | [237](/filings/0001193125-26-325027.md) | [284](/filings/0001193125-26-437000.md) | | Total liabilities | $m | [3,472](/filings/0001193125-26-437000.md) | [3,456](/filings/0001193125-26-243043.md) | [2,539](/filings/0001193125-26-325027.md) | [2,703](/filings/0001193125-26-437000.md) | | Long-term debt | $m | [2,606](/filings/0001193125-26-437000.md) | [2,625](/filings/0001193125-26-243043.md) | [1,718](/filings/0001193125-26-325027.md) | [1,719](/filings/0001193125-26-437000.md) | | Current portion of debt | $m | [26.9](/filings/0001193125-26-437000.md) | [27.1](/filings/0001193125-26-243043.md) | [0.1](/filings/0001193125-26-325027.md) | [0.1](/filings/0001193125-26-437000.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent ## Cash flow | Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [20.8](/filings/0001193125-26-243043.md) | [47.8 d](/filings/0001193125-26-325027.md) | [77.7 d](/filings/0001193125-26-437000.md) | [36.5](/filings/0001193125-26-243043.md) | [138 d](/filings/0001193125-26-325027.md) | [169 d](/filings/0001193125-26-437000.md) | | Capital expenditure | $m | [8.8](/filings/0001193125-26-243043.md) | [12.6 d](/filings/0001193125-26-325027.md) | [8.8 d](/filings/0001193125-26-437000.md) | [11.7](/filings/0001193125-26-243043.md) | [10.6 d](/filings/0001193125-26-325027.md) | [19.5 d](/filings/0001193125-26-437000.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets ## Shares | Line item | Unit | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | | Diluted shares (weighted) | millions of shares | [402](/filings/0001193125-26-325027.md) | [427](/filings/0001193125-26-437000.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 07:56 ET. No prices; not investment advice.